Varex Imaging Corp
For the period ended Oct 3, 2025. Filed Nov 18, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Nov 18, 2025
VREX$18.450.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders' Equity for the fiscal years
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
| Common Stock · Additional Paid-in Capital · Accumulated Other Comprehensive income (loss) · Retained Earnings (Accumulated Deficit) · Total Varex Equity · Noncontrolling Interests · Total Stockholders' Equity | ||||||||
|---|---|---|---|---|---|---|---|---|
| (In millions) · Shares · Amount | ||||||||
| September 30, 2022 | 40.1 | $0.4 | $469.1 | $0.1 | $59.7 | $529.3 | $13.3 | $542.6 |
| Net income | — | — | — | — | 47.4 | 47.4 | 0.5 | 47.9 |
| Cumulative effect of accounting change | — | — | (34.6) | — | 6.1 | (28.5) | — | (28.5) |
| Exercise of stock options | — | — | 0.2 | — | — | 0.2 | — | 0.2 |
| Common stock issued upon vesting of restricted shares | 0.2 | — | — | — | — | — | — | — |
| Shares withheld on vesting of restricted stock | (0.1) | — | (1.4) | — | — | (1.4) | — | (1.4) |
| Common stock issued under employee stock purchase plan | 0.3 | — | 3.9 | — | — | 3.9 | — | 3.9 |
| Share-based compensation | — | — | 13.5 | — | — | 13.5 | — | 13.5 |
| Realized gain on forward contracts | — | — | — | 0.1 | — | 0.1 | — | 0.1 |
| Unrealized gain on change in fair value of available-for-sale securities | — | — | — | 0.1 | — | 0.1 | — | 0.1 |
| Unrealized loss on defined benefit obligations, net of tax | — | — | — | (1.0) | — | (1.0) | — | (1.0) |
| Foreign currency translation adjustments | — | — | — | (0.5) | — | (0.5) | — | (0.5) |
| Other | — | — | (0.3) | — | — | (0.3) | (0.5) | (0.8) |
| September 29, 2023 | 40.5 | $0.4 | $450.4 | $(1.2) | $113.2 | $562.8 | $13.3 | $576.1 |
| Net (loss) income | — | — | — | — | (48.8) | (48.8) | 0.5 | (48.3) |
| Common stock issued upon vesting of restricted shares | 0.4 | — | — | — | — | — | — | — |
| Shares withheld on vesting of restricted stock | (0.1) | — | (2.2) | — | — | (2.2) | — | (2.2) |
| Common stock issued under employee stock purchase plan | 0.3 | — | 3.8 | — | — | 3.8 | — | 3.8 |
| Share-based compensation | — | — | 15.2 | — | — | 15.2 | — | 15.2 |
| Realized gain on forward contracts | — | — | — | 0.1 | — | 0.1 | — | 0.1 |
| Unrealized gain on change in fair value of available-for-sale securities | — | — | — | 0.1 | — | 0.1 | — | 0.1 |
| Foreign currency translation adjustments | — | — | — | (1.9) | — | (1.9) | — | (1.9) |
| Business acquisitions | — | — | — | — | — | — | 0.7 | 0.7 |
| Other | — | — | — | — | — | — | (0.4) | (0.4) |
| September 27, 2024 | 41.1 | $0.4 | $467.2 | $(2.9) | $64.4 | $529.1 | $14.1 | $543.2 |
| Net (loss) income | — | — | — | — | (70.3) | (70.3) | 0.4 | (69.9) |
| Common stock issued upon vesting of restricted shares | 0.4 | — | — | — | — | — | — | — |
| Shares withheld on vesting of restricted stock | (0.1) | — | (1.9) | — | — | (1.9) | — | (1.9) |
| Common stock issued under employee stock purchase plan | 0.3 | — | 3.3 | — | — | 3.3 | — | 3.3 |
| Share-based compensation | — | — | 14.8 | — | — | 14.8 | — | 14.8 |
| Realized gain on forward contracts | — | — | — | 0.1 | — | 0.1 | — | 0.1 |
| Unrealized loss on change in fair value of available-for-sale securities | — | — | — | (0.1) | — | (0.1) | — | (0.1) |
| Foreign currency translation adjustments | — | — | — | (2.3) | — | (2.3) | — | (2.3) |
| Other | — | — | (0.1) | — | — | (0.1) | (0.5) | (0.6) |
| October 3, 2025 | 41.7 | $0.4 | $483.3 | $(5.2) | $(5.9) | $472.6 | $14.0 | $486.6 |
See accompanying Notes to the Consolidated Financial Statements
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.